M.D.
Hematologist
1990, Albany Medical College, Albany, NY, M.D., Medicine
1988, Union College, Schenectady, NY, B.S., Biology/Modern Languages
1996 - 1997, Clinical Fellow, Bone Marrow Transplantation City of Hope
1993 - 1996, Clinical Fellow, Hematology-oncology Beth Israel Hospital, Harvard University Boston MA
1993 - 1996, Clinical Fellow Clinical Fellow in Medicine, Harvard Medical School Boston MA
1995 - 1996, Research Fellow Division of Hematologic Malignancies, Principal Investigator, J. Ritz Dana Farber Cancer Institute Harvard University, Boston MA
1995, Clinical Fellow, Bone Marrow Transplantation Fred Hutchinson Cancer Research Center, University of Washington Seattle WA
1995, Clinical Fellow, Bone Marrow Transplantation, Solid Tumor and Lymphoma Autologous Marrow Program Dana Farber Cancer Institute and Beth Israel Hospital, Boston, MA
1991 - 1993, Strong Memorial Hospital University of Rochester, Rochester, NY
2022-present, Executive Medical Director, Hematology, City of Hope Orange County
2021-present, Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
2015-present, Director, Judy and Bernard Briskin Center for Myeloma, City of Hope, Duarte, CA
2004-2018, Associate Director, Medical Education and Training, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope
1997-present, Staff Physician, Department of Hematology and Hematopoietic Cell Transplantation City of Hope
Amrita Krishnan, M.D., is the executive director of hematology for City of Hope’s® Orange County Lennar Foundation Cancer Center and the director of City of Hope Cancer Center Duarte’s Judy and Bernard Briskin Multiple Myeloma Center. A dedicated physician and a pioneering researcher, Dri Krishnan has been with the institution since 1996 and is a nationally renowned expert in stem cell transplantation and blood cancers.
Early in her career, Dr. Krishnan helped change the outlook for HIV positive patients with lymphoma by successfully introducing transplant therapies, at a time when many doubted that these patients could withstand such treatments.
Dr. Krishnan trained at top institutions including the University of Rochester in New York state, Beth Israel Hospital and the Dana-Farber Cancer Institute in Boston and the Fred Hutchinson Cancer Research Center in Seattle. She is a steering committee member of the Multiple Myeloma Research Foundation, represents North America in the International Myeloma Society and has co-chaired some of the largest national clinical trials focused on myeloma transplant therapies. Her current research focuses on developing new treatments for relapsed myeloma and uncovering how the disease resists therapy, with the ultimate goal of improving outcomes for patients everywhere.